应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
AVXL Anavex Life Sciences Corp.
已收盘 07-14 16:00:00 EDT
11.48
+0.37
+3.33%
盘后
11.37
-0.11
-0.96%
19:59 EDT
最高
11.56
最低
11.01
成交量
100.11万
今开
11.01
昨收
11.11
日振幅
4.95%
总市值
9.80亿
流通市值
9.47亿
总股本
8,537万
成交额
1,140万
换手率
1.21%
流通股本
8,253万
市净率
9.82
ROE
-40.17%
每股收益
-0.56
52周最高
14.44
52周最低
4.93
市盈率
-20.65
股息
0.00
股息收益率
0.00
ROA
-25.44%
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Anavex Life Sciences Corp.盘中异动 急速上涨5.00%
市场透视 · 07-09
Anavex Life Sciences Corp.盘中异动 急速上涨5.00%
Anavex Life Sciences Corp.盘中异动 早盘股价大跌6.12%
市场透视 · 07-07
Anavex Life Sciences Corp.盘中异动 早盘股价大跌6.12%
Anavex Life Sciences Corp.盘中异动 股价大涨5.57%报9.85美元
市场透视 · 07-02
Anavex Life Sciences Corp.盘中异动 股价大涨5.57%报9.85美元
Anavex Life Sciences Corp.盘中异动 下午盘股价大涨5.05%
市场透视 · 06-24
Anavex Life Sciences Corp.盘中异动 下午盘股价大涨5.05%
Anavex Life Sciences Corp.盘中异动 快速拉升5.04%
市场透视 · 06-16
Anavex Life Sciences Corp.盘中异动 快速拉升5.04%
Anavex Life Sciences Corp.盘中异动 早盘大幅拉升5.01%报8.17美元
市场透视 · 06-06
Anavex Life Sciences Corp.盘中异动 早盘大幅拉升5.01%报8.17美元
Anavex Life Sciences Corp.2025财年第一财季实现净利润-11.20百万美元,同比减少6.16%
市场透视 · 05-18
Anavex Life Sciences Corp.2025财年第一财季实现净利润-11.20百万美元,同比减少6.16%
Anavex Life Sciences Corp.盘中异动 早盘大幅上涨5.17%报8.54美元
市场透视 · 05-14
Anavex Life Sciences Corp.盘中异动 早盘大幅上涨5.17%报8.54美元
异动解读 | 财报优于预期仍未能提振,Anavex生命科学盘中大跌5.15%
异动解读 · 05-13
异动解读 | 财报优于预期仍未能提振,Anavex生命科学盘中大跌5.15%
Anavex Life Sciences Corp.盘中异动 临近午盘股价大跌5.05%
市场透视 · 05-06
Anavex Life Sciences Corp.盘中异动 临近午盘股价大跌5.05%
Anavex Life Sciences Corp.盘中异动 早盘股价大跌5.02%报8.89美元
市场透视 · 05-05
Anavex Life Sciences Corp.盘中异动 早盘股价大跌5.02%报8.89美元
Anavex Life Sciences Corp.盘中异动 早盘大幅上涨5.86%报9.75美元
市场透视 · 04-23
Anavex Life Sciences Corp.盘中异动 早盘大幅上涨5.86%报9.75美元
Anavex Life Sciences Corp.盘中异动 股价大涨5.02%
市场透视 · 04-22
Anavex Life Sciences Corp.盘中异动 股价大涨5.02%
Anavex Life Sciences Corp.盘中异动 下午盘股价大跌5.04%报8.66美元
市场透视 · 04-16
Anavex Life Sciences Corp.盘中异动 下午盘股价大跌5.04%报8.66美元
Anavex Life Sciences Corp.盘中异动 快速上涨5.15%
市场透视 · 04-11
Anavex Life Sciences Corp.盘中异动 快速上涨5.15%
Anavex Life Sciences Corp.盘中异动 临近午盘股价大涨5.07%
市场透视 · 03-10
Anavex Life Sciences Corp.盘中异动 临近午盘股价大涨5.07%
Anavex Life Sciences Corp.盘中异动 急速拉升5.12%
市场透视 · 03-03
Anavex Life Sciences Corp.盘中异动 急速拉升5.12%
Anavex Life Sciences Corp.盘中异动 股价大涨5.05%
市场透视 · 02-18
Anavex Life Sciences Corp.盘中异动 股价大涨5.05%
Anavex Life Sciences Corp.盘中异动 股价大涨5.37%报8.93美元
市场透视 · 02-14
Anavex Life Sciences Corp.盘中异动 股价大涨5.37%报8.93美元
Anavex生命科学公司2025年第一季度GAAP每股收益$(0.14)好于预期$(0.19),截至2024年12月31日公司现金及现金等价物为1.208亿美元,按当前现金使用率和范围预计可维持约4年
财报速递 · 02-12
Anavex生命科学公司2025年第一季度GAAP每股收益$(0.14)好于预期$(0.19),截至2024年12月31日公司现金及现金等价物为1.208亿美元,按当前现金使用率和范围预计可维持约4年
加载更多
公司概况
公司名称:
Anavex Life Sciences Corp.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Anavex Life Sciences Corp.成立于2004年1月23日,位于内华达州。是一家临床阶段的生物制药公司,致力于开发差异化疗法,将精准医学应用于高度未满足需求的中枢神经系统(CNS)疾病。该公司目前有两个核心计划和两个种子计划。该公司的核心计划处于神经退行性疾病和神经发育疾病的临床和临床前开发的各个阶段。
发行价格:
--
{"stockData":{"symbol":"AVXL","market":"US","secType":"STK","nameCN":"Anavex Life Sciences Corp.","latestPrice":11.48,"timestamp":1752523200000,"preClose":11.11,"halted":0,"volume":1001118,"hourTrading":{"tag":"盘后","latestPrice":11.37,"preClose":11.48,"latestTime":"19:59 EDT","volume":31750,"amount":364354.7142,"timestamp":1752537556603},"delay":0,"floatShares":82526066,"shares":85371852,"eps":-0.555893,"marketStatus":"已收盘","change":0.37,"latestTime":"07-14 16:00:00 EDT","open":11.01,"high":11.56,"low":11.01,"amount":11399995.96227,"amplitude":0.049505,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.555893,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752566400000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":11.11,"preHourTrading":{"tag":"盘前","latestPrice":11.18,"preClose":11.11,"latestTime":"09:17 EDT","volume":2585,"amount":28605.219665,"timestamp":1752499030025},"postHourTrading":{"tag":"盘后","latestPrice":11.37,"preClose":11.48,"latestTime":"19:59 EDT","volume":31750,"amount":364354.7142,"timestamp":1752537556603},"volumeRatio":1.002209,"impliedVol":0.81,"impliedVolPercentile":0.556},"requestUrl":"/m/hq/s/AVXL","defaultTab":"news","newsList":[{"id":"2550654096","title":"Anavex Life Sciences Corp.盘中异动 急速上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550654096","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550654096?lang=zh_cn&edition=full","pubTime":"2025-07-10 00:41","pubTimestamp":1752079265,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日00时41分,Anavex Life Sciences Corp.股票出现异动,股价急速拉升5.00%。Anavex Life Sciences Corp.股票所在的生物技术行业中,整体涨幅为1.07%。Anavex Life Sciences Corp.公司简介:Anavex Life Sciences Corp 是一家临床阶段的生物制药公司,致力于通过精准医疗开发针对中枢神经系统疾病的差异化治疗药物,这些疾病存在高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710004105979fdeb9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710004105979fdeb9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVXL"],"gpt_icon":0},{"id":"2549055581","title":"Anavex Life Sciences Corp.盘中异动 早盘股价大跌6.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549055581","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549055581?lang=zh_cn&edition=full","pubTime":"2025-07-07 22:40","pubTimestamp":1751899219,"startTime":"0","endTime":"0","summary":"北京时间2025年07月07日22时40分,Anavex Life Sciences Corp.股票出现异动,股价快速下跌6.12%。Anavex Life Sciences Corp.股票所在的生物技术行业中,整体跌幅为0.33%。Anavex Life Sciences Corp.公司简介:Anavex Life Sciences Corp 是一家临床阶段的生物制药公司,致力于通过精准医疗开发针对中枢神经系统疾病的差异化治疗药物,这些疾病存在高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707224019a69b32f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707224019a69b32f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVXL"],"gpt_icon":0},{"id":"2548781649","title":"Anavex Life Sciences Corp.盘中异动 股价大涨5.57%报9.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548781649","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548781649?lang=zh_cn&edition=full","pubTime":"2025-07-02 23:35","pubTimestamp":1751470533,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日23时35分,Anavex Life Sciences Corp.股票出现波动,股价大幅拉升5.57%。截至发稿,该股报9.85美元/股,成交量21.5971万股,换手率0.25%,振幅5.29%。Anavex Life Sciences Corp.股票所在的生物技术行业中,整体涨幅为1.00%。Anavex Life Sciences Corp.公司简介:Anavex Life Sciences Corp 是一家临床阶段的生物制药公司,致力于通过精准医疗开发针对中枢神经系统疾病的差异化治疗药物,这些疾病存在高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702233534a72aea6a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702233534a72aea6a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVXL","BK4139"],"gpt_icon":0},{"id":"2546423080","title":"Anavex Life Sciences Corp.盘中异动 下午盘股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546423080","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546423080?lang=zh_cn&edition=full","pubTime":"2025-06-25 02:40","pubTimestamp":1750790454,"startTime":"0","endTime":"0","summary":"北京时间2025年06月25日02时40分,Anavex Life Sciences Corp.股票出现异动,股价大幅拉升5.05%。截至发稿,该股报9.77美元/股,成交量77.9162万股,换手率0.91%,振幅6.02%。Anavex Life Sciences Corp.股票所在的生物技术行业中,整体涨幅为2.04%。Anavex Life Sciences Corp.公司简介:Anavex Life Sciences Corp 是一家临床阶段的生物制药公司,致力于通过精准医疗开发针对中枢神经系统疾病的差异化治疗药物,这些疾病存在高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506250240549529f0e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506250240549529f0e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVXL"],"gpt_icon":0},{"id":"2543606709","title":"Anavex Life Sciences Corp.盘中异动 快速拉升5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2543606709","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543606709?lang=zh_cn&edition=full","pubTime":"2025-06-16 22:46","pubTimestamp":1750085218,"startTime":"0","endTime":"0","summary":"北京时间2025年06月16日22时46分,Anavex Life Sciences Corp.股票出现波动,股价快速上涨5.04%。截至发稿,该股报8.44美元/股,成交量14.9343万股,换手率0.17%,振幅4.55%。Anavex Life Sciences Corp.股票所在的生物技术行业中,整体涨幅为0.48%。Anavex Life Sciences Corp.公司简介:Anavex Life Sciences Corp 是一家临床阶段的生物制药公司,致力于通过精准医疗开发针对中枢神经系统疾病的差异化治疗药物,这些疾病存在高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616224659a70c53a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616224659a70c53a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVXL"],"gpt_icon":0},{"id":"2541109869","title":"Anavex Life Sciences Corp.盘中异动 早盘大幅拉升5.01%报8.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541109869","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541109869?lang=zh_cn&edition=full","pubTime":"2025-06-06 22:47","pubTimestamp":1749221243,"startTime":"0","endTime":"0","summary":"北京时间2025年06月06日22时47分,Anavex Life Sciences Corp.股票出现异动,股价大幅上涨5.01%。截至发稿,该股报8.17美元/股,成交量15.2582万股,换手率0.18%,振幅4.88%。Anavex Life Sciences Corp.股票所在的生物技术行业中,整体涨幅为0.29%。Anavex Life Sciences Corp.公司简介:Anavex Life Sciences Corp 是一家临床阶段的生物制药公司,致力于通过精准医疗开发针对中枢神经系统疾病的差异化治疗药物,这些疾病存在高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606224724977480b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606224724977480b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVXL","BK4139"],"gpt_icon":0},{"id":"2536759412","title":"Anavex Life Sciences Corp.2025财年第一财季实现净利润-11.20百万美元,同比减少6.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536759412","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536759412?lang=zh_cn&edition=full","pubTime":"2025-05-19 00:01","pubTimestamp":1747584094,"startTime":"0","endTime":"0","summary":"5月19日,Anavex Life Sciences Corp.公布财报,公告显示公司2025财年第一财季净利润为-11.20百万美元,同比减少6.16%;其中营业收入为0.00美元,每股基本收益为-0.13美元。从资产负债表来看,Anavex Life Sciences Corp.总负债17.38百万美元,其中短期债务0.00美元,资产负债比为0.07,流动比率为0.07。机构评级:截至2025年5月19日,当前有3家机构对Anavex Life Sciences Corp.目标价做出预测,其中目标均价为34.33美元,其中最低目标价为15.00美元,最高目标价为46.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000535a482f150&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000535a482f150&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVXL"],"gpt_icon":0},{"id":"2535020354","title":"Anavex Life Sciences Corp.盘中异动 早盘大幅上涨5.17%报8.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535020354","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535020354?lang=zh_cn&edition=full","pubTime":"2025-05-14 21:40","pubTimestamp":1747230045,"startTime":"0","endTime":"0","summary":"北京时间2025年05月14日21时40分,Anavex Life Sciences Corp.股票出现异动,股价急速拉升5.17%。截至发稿,该股报8.54美元/股,成交量10.0384万股,换手率0.12%,振幅3.20%。Anavex Life Sciences Corp.股票所在的生物技术行业中,整体涨幅为0.26%。Anavex Life Sciences Corp.公司简介:Anavex Life Sciences Corp 是一家临床阶段的生物制药公司,致力于通过精准医疗开发针对中枢神经系统疾病的差异化治疗药物,这些疾病存在高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514214046a47e4041&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514214046a47e4041&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVXL","BK4139"],"gpt_icon":0},{"id":"1107886975","title":"异动解读 | 财报优于预期仍未能提振,Anavex生命科学盘中大跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=1107886975","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107886975?lang=zh_cn&edition=full","pubTime":"2025-05-13 23:23","pubTimestamp":1747149801,"startTime":"0","endTime":"0","summary":"生物技术公司Anavex Life Sciences Corp.今日盘中股价大跌5.15%,引发市场关注。根据Anavex Life Sciences发布的截至3月31日的季度财报显示,公司调整后每股亏损为13美分,好于分析师平均预期的15美分亏损。值得注意的是,尽管业绩表现略好于预期,但公司股价今年迄今已下跌20.4%。分析人士普遍对Anavex Life Sciences持积极态度,目前对该公司股票的平均评级为\"买入\",12个月目标价中位数为42.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | 财报优于预期仍未能提振,Anavex生命科学盘中大跌5.15%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["AVXL"],"gpt_icon":0},{"id":"2533404651","title":"Anavex Life Sciences Corp.盘中异动 临近午盘股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533404651","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533404651?lang=zh_cn&edition=full","pubTime":"2025-05-06 23:50","pubTimestamp":1746546643,"startTime":"0","endTime":"0","summary":"北京时间2025年05月06日23时50分,Anavex Life Sciences Corp.股票出现异动,股价快速下挫5.05%。Anavex Life Sciences Corp.股票所在的生物技术行业中,整体跌幅为4.99%。Anavex Life Sciences Corp.公司简介:Anavex Life Sciences Corp 是一家临床阶段的生物制药公司,致力于通过精准医疗开发针对中枢神经系统疾病的差异化治疗药物,这些疾病存在高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505062350439750db34&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505062350439750db34&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVXL"],"gpt_icon":0},{"id":"2533538250","title":"Anavex Life Sciences Corp.盘中异动 早盘股价大跌5.02%报8.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533538250","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533538250?lang=zh_cn&edition=full","pubTime":"2025-05-05 22:09","pubTimestamp":1746454161,"startTime":"0","endTime":"0","summary":"北京时间2025年05月05日22时09分,Anavex Life Sciences Corp.股票出现波动,股价快速跳水5.02%。截至发稿,该股报8.89美元/股,成交量18.1406万股,换手率0.21%,振幅5.61%。Anavex Life Sciences Corp.股票所在的生物技术行业中,整体涨幅为0.34%。Anavex Life Sciences Corp.公司简介:Anavex Life Sciences Corp 是一家临床阶段的生物制药公司,致力于通过精准医疗开发针对中枢神经系统疾病的差异化治疗药物,这些疾病存在高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250505220921a6d3e7b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250505220921a6d3e7b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVXL"],"gpt_icon":0},{"id":"2529711689","title":"Anavex Life Sciences Corp.盘中异动 早盘大幅上涨5.86%报9.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529711689","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529711689?lang=zh_cn&edition=full","pubTime":"2025-04-23 21:31","pubTimestamp":1745415062,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日21时31分,Anavex Life Sciences Corp.股票出现异动,股价大幅拉升5.86%。截至发稿,该股报9.75美元/股,成交量1.8741万股,换手率0.02%,振幅0.32%。Anavex Life Sciences Corp.股票所在的生物技术行业中,整体涨幅为0.57%。Anavex Life Sciences Corp.公司简介:Anavex Life Sciences Corp 是一家临床阶段的生物制药公司,致力于通过精准医疗开发针对中枢神经系统疾病的差异化治疗药物,这些疾病存在高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213102a6c53c31&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213102a6c53c31&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVXL"],"gpt_icon":0},{"id":"2529553768","title":"Anavex Life Sciences Corp.盘中异动 股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529553768","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529553768?lang=zh_cn&edition=full","pubTime":"2025-04-23 02:30","pubTimestamp":1745346625,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日02时30分,Anavex Life Sciences Corp.股票出现异动,股价大幅上涨5.02%。截至发稿,该股报9.20美元/股,成交量34.2166万股,换手率0.40%,振幅4.45%。Anavex Life Sciences Corp.股票所在的生物技术行业中,整体涨幅为1.98%。Anavex Life Sciences Corp.公司简介:Anavex Life Sciences Corp 是一家临床阶段的生物制药公司,致力于通过精准医疗开发针对中枢神经系统疾病的差异化治疗药物,这些疾病存在高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423023026aa2c76fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423023026aa2c76fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVXL"],"gpt_icon":0},{"id":"2528715832","title":"Anavex Life Sciences Corp.盘中异动 下午盘股价大跌5.04%报8.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528715832","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528715832?lang=zh_cn&edition=full","pubTime":"2025-04-17 02:52","pubTimestamp":1744829556,"startTime":"0","endTime":"0","summary":"北京时间2025年04月17日02时52分,Anavex Life Sciences Corp.股票出现异动,股价急速跳水5.04%。截至发稿,该股报8.66美元/股,成交量30.961万股,换手率0.36%,振幅4.50%。Anavex Life Sciences Corp.股票所在的生物技术行业中,整体跌幅为1.62%。Anavex Life Sciences Corp.公司简介:Anavex Life Sciences Corp 是一家临床阶段的生物制药公司,致力于通过精准医疗开发针对中枢神经系统疾病的差异化治疗药物,这些疾病存在高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417025237a45b740a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417025237a45b740a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVXL"],"gpt_icon":0},{"id":"2526485126","title":"Anavex Life Sciences Corp.盘中异动 快速上涨5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526485126","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2526485126?lang=zh_cn&edition=full","pubTime":"2025-04-12 03:24","pubTimestamp":1744399447,"startTime":"0","endTime":"0","summary":"北京时间2025年04月12日03时24分,Anavex Life Sciences Corp.股票出现异动,股价大幅拉升5.15%。Anavex Life Sciences Corp.股票所在的生物技术行业中,整体涨幅为2.15%。Anavex Life Sciences Corp.公司简介:Anavex Life Sciences Corp 是一家临床阶段的生物制药公司,致力于通过精准医疗开发针对中枢神经系统疾病的差异化治疗药物,这些疾病存在高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504120324089735a20d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504120324089735a20d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVXL","BK4139"],"gpt_icon":0},{"id":"2518743902","title":"Anavex Life Sciences Corp.盘中异动 临近午盘股价大涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518743902","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518743902?lang=zh_cn&edition=full","pubTime":"2025-03-10 23:37","pubTimestamp":1741621049,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日23时37分,Anavex Life Sciences Corp.股票出现异动,股价急速上涨5.07%。截至发稿,该股报9.11美元/股,成交量29.0493万股,换手率0.34%,振幅7.84%。Anavex Life Sciences Corp.股票所在的生物技术行业中,整体涨幅为0.59%。Anavex Life Sciences Corp.公司简介:Anavex Life Sciences Corp 是一家临床阶段的生物制药公司,致力于通过精准医疗开发针对中枢神经系统疾病的差异化治疗药物,这些疾病存在高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310233730a26a53ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310233730a26a53ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVXL","BK4139"],"gpt_icon":0},{"id":"2516860630","title":"Anavex Life Sciences Corp.盘中异动 急速拉升5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516860630","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516860630?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:15","pubTimestamp":1741014921,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时15分,Anavex Life Sciences Corp.股票出现波动,股价急速拉升5.12%。截至发稿,该股报8.32美元/股,成交量17.146万股,换手率0.20%,振幅4.68%。Anavex Life Sciences Corp.股票所在的生物技术行业中,整体跌幅为0.09%。Anavex Life Sciences Corp.公司简介:Anavex Life Sciences Corp 是一家临床阶段的生物制药公司,致力于通过精准医疗开发针对中枢神经系统疾病的差异化治疗药物,这些疾病存在高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303231521abe6419d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303231521abe6419d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVXL"],"gpt_icon":0},{"id":"2512169464","title":"Anavex Life Sciences Corp.盘中异动 股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512169464","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512169464?lang=zh_cn&edition=full","pubTime":"2025-02-18 23:14","pubTimestamp":1739891677,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日23时14分,Anavex Life Sciences Corp.股票出现异动,股价急速上涨5.05%。截至发稿,该股报8.95美元/股,成交量14.6079万股,换手率0.17%,振幅4.58%。Anavex Life Sciences Corp.股票所在的生物技术行业中,整体涨幅为0.84%。Anavex Life Sciences Corp.公司简介:Anavex Life Sciences Corp 是一家临床阶段的生物制药公司,致力于通过精准医疗开发针对中枢神经系统疾病的差异化治疗药物,这些疾病存在高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218231437a24ab690&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218231437a24ab690&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVXL"],"gpt_icon":0},{"id":"2511748699","title":"Anavex Life Sciences Corp.盘中异动 股价大涨5.37%报8.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511748699","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511748699?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:48","pubTimestamp":1739544527,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时48分,Anavex Life Sciences Corp.股票出现异动,股价快速拉升5.37%。截至发稿,该股报8.93美元/股,成交量6.3362万股,换手率0.07%,振幅5.19%。Anavex Life Sciences Corp.股票所在的生物技术行业中,整体涨幅为0.30%。Anavex Life Sciences Corp.公司简介:Anavex Life Sciences Corp 是一家临床阶段的生物制药公司,致力于通过精准医疗开发针对中枢神经系统疾病的差异化治疗药物,这些疾病存在高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214224847abcf0a89&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214224847abcf0a89&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVXL"],"gpt_icon":0},{"id":"1169314471","title":"Anavex生命科学公司2025年第一季度GAAP每股收益$(0.14)好于预期$(0.19),截至2024年12月31日公司现金及现金等价物为1.208亿美元,按当前现金使用率和范围预计可维持约4年","url":"https://stock-news.laohu8.com/highlight/detail?id=1169314471","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169314471?lang=zh_cn&edition=full","pubTime":"2025-02-12 20:56","pubTimestamp":1739364973,"startTime":"0","endTime":"0","summary":"Anavex生命科学公司报告季度亏损为每股$,好于分析师预期的每股$,超出26.32%。这一结果较去年同期每股亏损$下降了27.27%。以上内容来自Benzinga Earnings专栏,原文如下:Anavex Life Sciences reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 26.32 percent. This is a 27.27 percent decrease over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Anavex生命科学公司2025年第一季度GAAP每股收益$(0.14)好于预期$(0.19),截至2024年12月31日公司现金及现金等价物为1.208亿美元,按当前现金使用率和范围预计可维持约4年","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVXL"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.anavex.com","stockEarnings":[{"period":"1week","weight":0.0297},{"period":"1month","weight":0.3549},{"period":"3month","weight":0.254},{"period":"6month","weight":-0.0107},{"period":"1year","weight":1.249},{"period":"ytd","weight":0.0345}],"compareEarnings":[{"period":"1week","weight":-0.0028},{"period":"1month","weight":0.037},{"period":"3month","weight":0.168},{"period":"6month","weight":0.0743},{"period":"1year","weight":0.1207},{"period":"ytd","weight":0.0641}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Anavex Life Sciences Corp.成立于2004年1月23日,位于内华达州。是一家临床阶段的生物制药公司,致力于开发差异化疗法,将精准医学应用于高度未满足需求的中枢神经系统(CNS)疾病。该公司目前有两个核心计划和两个种子计划。该公司的核心计划处于神经退行性疾病和神经发育疾病的临床和临床前开发的各个阶段。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.045456},{"month":2,"riseRate":0.5,"avgChangeRate":0.134476},{"month":3,"riseRate":0.6,"avgChangeRate":0.076429},{"month":4,"riseRate":0.3,"avgChangeRate":-0.072663},{"month":5,"riseRate":0.7,"avgChangeRate":0.033993},{"month":6,"riseRate":0.7,"avgChangeRate":0.16895},{"month":7,"riseRate":0.5,"avgChangeRate":-0.032033},{"month":8,"riseRate":0.444444,"avgChangeRate":-0.024515},{"month":9,"riseRate":0.555556,"avgChangeRate":0.020112},{"month":10,"riseRate":0.555556,"avgChangeRate":0.007649},{"month":11,"riseRate":0.4,"avgChangeRate":0.020111},{"month":12,"riseRate":0.5,"avgChangeRate":-0.021451}],"exchange":"NASDAQ","name":"Anavex Life Sciences Corp.","nameEN":"Anavex Life Sciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Anavex Life Sciences Corp.(AVXL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Anavex Life Sciences Corp.(AVXL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Anavex Life Sciences Corp.,AVXL,Anavex Life Sciences Corp.股票,Anavex Life Sciences Corp.股票老虎,Anavex Life Sciences Corp.股票老虎国际,Anavex Life Sciences Corp.行情,Anavex Life Sciences Corp.股票行情,Anavex Life Sciences Corp.股价,Anavex Life Sciences Corp.股市,Anavex Life Sciences Corp.股票价格,Anavex Life Sciences Corp.股票交易,Anavex Life Sciences Corp.股票购买,Anavex Life Sciences Corp.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Anavex Life Sciences Corp.(AVXL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Anavex Life Sciences Corp.(AVXL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}